EUVIMEDEUVIMED entdecken
Crossref

Validation of ICH Q2(R2) compliant flow cytometry-based Quality Control for the characterization of CAR-NK cell products

J Schlueter, S Palm, F Gierschek, D Schmiedel, M Bremm, O Zimmermann, L Puth, U Koehl, J H Klusmann, H Bönig, P Bader, E Ullrich und 2 weitere

Klinische Pädiatrie · 01.05.2024 · 236 (03) · 213

DOI: 10.1055/s-0044-1786617 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Klinische Pädiatrie, erschienen am 01.05.2024. Verfasst von J Schlueter und 13 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In the last decade, cellular immunotherapies using genetically engineered cells to express chimeric antigen receptors (CAR) have made tremendous progress. In order to safely apply CAR-NK cell products in the context of a clinical trial or further as an ATMP, GMP-compliant manufacturing and Quality Control (QC) is essential. Regulatory requirements for QC of ATMPs are extensive and have to include test specifications such as identity, purity, impurities, quantity, potency and safety. By developing 3 robust 13-color single-platform immunophenotyping panels on the DxFLEX cytometer we are able to determine multiple test specifications at once while analyzing cytotoxicity and fitness of the cells. Killing-superiority of CAR-NK cells over untransduced cells is demonstrated also by a flow-based potency assay. The optimized quality control is currently being validated following the guidelines of the International Council for Harmonisation (ICH) Q2 (R2), addressing validation parameters such as specificity, accuracy, stability and robustness. This ensures precise description of the pharmacologically active and contaminating cell populations for a safe CAR-NK cell product application. Publication History Article published online: 10 May 2024 © 2024. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany

Zitieren

APA

Schlueter, J., Palm, S., Gierschek, F., Schmiedel, D., Bremm, M., Zimmermann, O., Puth, L., Koehl, U., Klusmann, J. H., Bönig, H., Bader, P., Ullrich, E., Huenecke, S., & Cappel, C. (2024). Validation of ICH Q2(R2) compliant flow cytometry-based Quality Control for the characterization of CAR-NK cell products. Klinische Pädiatrie, 236(03), 213. https://doi.org/10.1055/s-0044-1786617

Vancouver

Schlueter J, Palm S, Gierschek F, Schmiedel D, Bremm M, Zimmermann O, et al. Validation of ICH Q2(R2) compliant flow cytometry-based Quality Control for the characterization of CAR-NK cell products. Klinische Pädiatrie. 2024;236(03):213. doi:10.1055/s-0044-1786617

BibTeX
@article{Schlueter2024,
  author = {Schlueter, J and Palm, S and Gierschek, F and Schmiedel, D and Bremm, M and Zimmermann, O and Puth, L and Koehl, U and Klusmann, J H and Bönig, H and Bader, P and Ullrich, E and Huenecke, S and Cappel, C},
  title = {Validation of ICH Q2(R2) compliant flow cytometry-based Quality Control for the characterization of CAR-NK cell products},
  journal = {Klinische Pädiatrie},
  year = {2024},
  volume = {236},
  number = {03},
  pages = {213},
  doi = {10.1055/s-0044-1786617}
}
Kostenlos starten →